Also, tetrabenazine, a dopamine-depleting drug that inhibits the vesicular monoamine transporter 2 (VMAT2), is effective for various hyperkinetic movement disorders, including TS [17,18]. Here, SLC18A2 is linked to Timothy syndrome.